Englander Institute for Precision Medicine
PMI

EIPM to participate in White House-Led Precision Medicine Initiative

July 8, 2016

Moving with what has been cited as unprecedented speed, the National Institutes of Health (NIH) has chosen a collaboration of four New York institutions — Weill Cornell Medicine, NewYork-Presbyterian Hospital, Columbia University Hospital and NYC Health + Hospitals/Harlem — to launch a landmark longitudinal research study as a part of President Barack Obama’s Precision Medicine Initiative (PMI).

The PMI Cohort Program aims to collect health, lifestyle and genetic information from 1...

Read More
Source: White House

Defining Our Cancer Moonshot

July 2, 2016

In what evolved into a cancer moonshot think tank, a special event was held at Weill Cornell Medicine on June 29, one of 270 held in tandem across the United States convened by Vice President Joe Biden, with a national summit at Howard University in Washington, DC.

Biden invited regional participants to discuss the goals of the “Cancer Moonshot” mission, announced in January by President Barack Obama as a way to accelerate cancer...

Read More
Source: EIPM

Sequencing Reveals Molecular Underpinnings of Aggressive Prostate Cancer Subtype

February 9, 2016

A subset of treatment-resistant prostate cancer pathologically resembles small cell lung cancer rather than typical prostate cancer, Weill Cornell Medicine and University of Trento investigators discovered in a new study. The scientists say their findings may lead to more effective ways to diagnose and treat neuroendocrine prostate cancer.

Therapies that cut off the...

Read More